BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Sparchez Z, Radu P, Bartos A, Nenu I, Craciun R, Mocan T, Horhat A, Spârchez M, Dufour JF. Combined treatments in hepatocellular carcinoma: Time to put them in the guidelines? World J Gastrointest Oncol 2021; 13(12): 1896-1918 [PMID: 35070032 DOI: 10.4251/wjgo.v13.i12.1896]
URL: https://www.wjgnet.com/1948-5204/full/v13/i12/1896.htm
Number Citing Articles
1
Dehai Wu, Guanqun Liao, Yuanfei Yao, Lining Huang, Bowen Dong, Yong Ma, Guangchao Yang. Downregulated Acetyl-CoA Acyltransferase 2 Promoted the Progression of Hepatocellular Carcinoma and Participated in the Formation of Immunosuppressive MicroenvironmentJournal of Hepatocellular Carcinoma 2023; : 1327 doi: 10.2147/JHC.S418429
2
Paul Tucan, Calin Vaida, Daniel Horvath, Andrei Caprariu, Alin Burz, Bogdan Gherman, Stefan Iakab, Doina Pisla. Design and Experimental Setup of a Robotic Medical Instrument for Brachytherapy in Non-Resectable Liver TumorsCancers 2022; 14(23): 5841 doi: 10.3390/cancers14235841
3
Cody R Criss, Mina S Makary. Salvage locoregional therapies for recurrent hepatocellular carcinomaWorld Journal of Gastroenterology 2023; 29(3): 413-424 doi: 10.3748/wjg.v29.i3.413
4
Anna Podlasek, Maheeba Abdulla, Dieter Broering, Khalid Bzeizi. Recent Advances in Locoregional Therapy of Hepatocellular CarcinomaCancers 2023; 15(13): 3347 doi: 10.3390/cancers15133347
5
Jing Liang, Yi Bai, Fu-Shuang Ha, Ying Luo, Hui-Ting Deng, Ying-Tang Gao. Combining local regional therapy and systemic therapy: Expected changes in the treatment landscape of recurrent hepatocellular carcinomaWorld Journal of Gastrointestinal Oncology 2023; 15(1): 1-18 doi: 10.4251/wjgo.v15.i1.1